Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microbial Transplant Therapy in Recurrent Calcium-Oxalate Kidney Stones
NCT05516472Phase 1Recruiting
- Start
- Oct 2024
- Primary completion
- Dec 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label trial of microbial transplant therapy in calcium oxalate nephrolithiasis (2 arms). Primary endpoints: Change in 24-hour urinary oxalate concentration from baseline at 5 weeks, Change in 24-hour urinary calcium concentration from baseline at 5 weeks and 1 more. Started Oct 2024; status: recruiting.
02
Drugs
microbial transplant therapy
03
Conditions
calcium oxalate nephrolithiasis
Beyond the preview
Go deeper on NCT05516472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05516472.